CRYSVITA
- Product NDC
- 42747-304
- 11-digit product format
- 427470304
- Labeler code
- 42747
- Product ID
- 42747-304_59579885-f5a8-41ba-bfc7-5e3adcc1cbce
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Burosumab
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- Kyowa Kirin, Inc.
- Application
- BLA761068
- Marketing category
- BLA
- Marketing start
- 2018-04-18
- Substance
- BUROSUMAB
- Active strength
- 30 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CRYSVITA
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BUROSUMAB | 30 mg/mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | G9WJT6RD29 |
| Rxcui | 2043859, 2043864, 2043868, 2043870, 2043876, 2043878 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 5da468b5-2d28-44fa-af0c-327e5587cf7f | Product name | 1 | 20180619 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42747-304-01 | CRYSVITA | 1 mL in 1 VIAL, SINGLE-USE | INJECTION | 1 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42747-304-01 | ML - Milliliter | 42747-304 | 36915c30-9392-4ffc-914b-1ea796c6525c | 1 | 2023-09-05 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2043859 | burosumab-twza 10 MG in 1 ML Injection | PSN | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043868 | burosumab-twza 20 MG in 1 ML Injection | PSN | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043876 | burosumab-twza 30 MG in 1 ML Injection | PSN | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043864 | CRYSViTA 10 MG in 1 ML Injection | PSN | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043870 | CRYSViTA 20 MG in 1 ML Injection | PSN | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043878 | CRYSViTA 30 MG in 1 ML Injection | PSN | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043864 | 1 ML burosumab-twza 10 MG/ML Injection [Crysvita] | SBD | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043870 | 1 ML burosumab-twza 20 MG/ML Injection [Crysvita] | SBD | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043878 | 1 ML burosumab-twza 30 MG/ML Injection [Crysvita] | SBD | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043859 | 1 ML burosumab-twza 10 MG/ML Injection | SCD | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043868 | 1 ML burosumab-twza 20 MG/ML Injection | SCD | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043876 | 1 ML burosumab-twza 30 MG/ML Injection | SCD | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043859 | burosumab-twza 10 MG per 1 ML Injection | SY | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043868 | burosumab-twza 20 MG per 1 ML Injection | SY | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043876 | burosumab-twza 30 MG per 1 ML Injection | SY | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043864 | Crysvita 10 MG per 1 ML Injection | SY | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043870 | Crysvita 20 MG per 1 ML Injection | SY | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
| 2043878 | Crysvita 30 MG per 1 ML Injection | SY | 102f96a0-6e3a-4fc1-b204-34d604683af6 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 42747-304-01 | 42747030401 | 1 mL in 1 VIAL, SINGLE-USE (42747-304-01) | 1 ml | 2023-09-01 | No | No | Historical |